GrowthWorks

HIGHLINE is a pre-seed investor and acceleration platform that supports digital startups in securing follow-on capital, leveraging a network of prominent venture capitalists from its offices in Vancouver and Toronto. Unlike traditional accelerators, HIGHLINE operates without rigid start or end dates, allowing founders to seek advice and support at any time. The platform offers access to a premium network and hosts monthly events for founders, fostering an environment for collaboration and growth. Additionally, HIGHLINE addresses fundraising challenges and collaborates with incubators to provide specialized programming tailored to the needs of emerging companies. The organization was formed in August 2014 through the merger of Growlab Ventures and Extreme Startups.

General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

BuildDirect Technologies Inc. operates an online marketplace that connects homeowners and home improvement professionals in North America with global suppliers of building materials. Founded in 1999 and based in Vancouver, Canada, the company offers a wide range of products, including flooring, decking, tiles, and other building materials. Its platform facilitates the buying and selling of these materials, enhancing accessibility for consumers and professionals alike. BuildDirect's services also include BuildDirect Gateway, a global supply chain platform that provides third parties with access to advanced warehousing and logistics solutions, streamlining the shipping process from manufacturing to last-mile delivery. The company generates the majority of its revenue from its primary platform in the United States.

ResponseTek Networks Corp. is a leading provider of Customer Experience Management (CEM) software, focused on enhancing customer satisfaction by transforming customer feedback into actionable insights. The ResponseTek Listening Platform connects major corporations, including HSBC and Vodafone, with their customers across various touchpoints such as retail, call centers, and online services. By employing diverse methods, including SMS surveys and social media monitoring, ResponseTek enables organizations to obtain a comprehensive view of the customer experience, supported by both quantitative data and qualitative feedback. Headquartered in Vancouver, the company also has offices in Toronto and London, UK, and aims to integrate customer experience data across organizations to eliminate information silos and foster improvements in customer satisfaction.

General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

Boreal Genomics Inc. is a biotechnology company that focuses on the development and commercialization of technologies for blood-based detection and monitoring of circulating tumor DNA. Founded in 2007 and headquartered in Los Altos, California, with an additional office in Vancouver, Canada, the company offers products like OnTarget, which allows for the sensitive detection and quantification of tumor mutations in plasma or tissue. Boreal's platform is designed to enable healthcare professionals to perform accurate genomic profiling and monitor tumor evolution from cell-free DNA in plasma, thereby improving cancer patient care. The OnTarget assay, available as a research-use service, reveals tumor mutations that may be undetectable by other methods, assisting in therapy selection, enhancing clinical trial efficiency, and expediting drug development. Additionally, Boreal provides DNA enrichment and library construction solutions tailored for high accuracy sequencing in liquid biopsy applications.

Vitrium Systems Inc. specializes in document security and digital rights management (DRM) software tailored for various file formats, including PDF, office documents, and images. Founded in 2005 and based in Vancouver, Canada, the company provides solutions that allow content creators, publishers, and distributors to safeguard proprietary and confidential materials. Vitrium's offerings encompass document security, secure file sharing, image protection, and analytics, as well as consulting and support services. Its technology integrates seamlessly with existing enterprise systems, enabling organizations to implement military-grade encryption and file-level protection. This facilitates the secure distribution of documents and images through various channels, including websites and email, while providing insights into user engagement through tracking and auditing capabilities. Vitrium serves a diverse range of industries, including education, finance, media, and technology, and has reached a global audience of over a million users.

General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.

Mixpo, Inc. is a Seattle-based company that operates a comprehensive advertising platform specializing in social, display, and video advertising. Founded in 2002, Mixpo provides tools for advertisers, agencies, and media companies to create, deliver, and measure digital advertising campaigns effectively. The platform enhances campaign performance by integrating channels, assets, and providing advanced capabilities such as measurement, bid optimization, targeting, and retargeting. It also offers solutions tailored for brand advertisers, local creative services, national networks, and advertising exchanges. Known for its innovative technology and deep data insights, Mixpo facilitates ad verification and performance analysis across various demographics and devices. As of 2017, Mixpo functions as a subsidiary of Netsertive, Inc.

Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

Bootup Labs was a startup accelerator based in Vancouver, Canada, founded in 2008. It focused on assisting early-stage companies, particularly in the digital media sector, in becoming fundable ventures. The organization recruited promising entrepreneurs and provided them with essential resources, including mentorship, ongoing support, investment, and office space. Through its comprehensive approach, Bootup Labs aimed to help startups define their business models and secure venture financing, ultimately guiding eight companies from inception to a state of readiness for funding.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.

Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

QuIC Financial Technologies, Inc. specializes in developing simulation, risk calculation, and pricing platform solutions tailored for financial institutions and companies. The firm's QuIC product suite features an n-dimensional vector-based calculator designed to solve complex mathematical problems. Key products include the QuIC Engine, which delivers supercomputer-level performance on desktop computers, and QuIC Script, a vector computing language for formulating financial solutions. QuIC Analytics offers a range of instruments covering interest rate and foreign exchange derivatives, equities, commodities, hybrids, asset-backed securities, and credit derivatives, along with various utility function libraries. Additionally, QuIC provides the QuIC Workbench for developing and visualizing QuIC Script, as well as the QuIC Simulation Framework for enterprise-scale portfolio simulation. Integration products such as QuIC Dispatch and QuIC Bridge facilitate seamless connections with client solutions and existing models. The company also offers support services, system integration, custom development, and training resources. Headquartered in Vancouver, Canada, QuIC Financial Technologies operates additional offices in London and New York.

Mixpo, Inc. is a Seattle-based company that operates a comprehensive advertising platform specializing in social, display, and video advertising. Founded in 2002, Mixpo provides tools for advertisers, agencies, and media companies to create, deliver, and measure digital advertising campaigns effectively. The platform enhances campaign performance by integrating channels, assets, and providing advanced capabilities such as measurement, bid optimization, targeting, and retargeting. It also offers solutions tailored for brand advertisers, local creative services, national networks, and advertising exchanges. Known for its innovative technology and deep data insights, Mixpo facilitates ad verification and performance analysis across various demographics and devices. As of 2017, Mixpo functions as a subsidiary of Netsertive, Inc.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.